Collectively, our data suggest that IL-22 functions to promote BC renewal over differentiation and that downregulation of innate immune responses at late time points following PR8 infection with associated reduction in IL-22, serves as a trigger to promote basal to serous cell differentiation. The gene discussed is IL22; the disease is breast cancer.